A Pilot Study of CPT-11 and Cisplatin for Ovarian Clear Cell Adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Pilot Study of CPT-11 and Cisplatin for Ovarian Clear Cell Adenocarcinoma

Published:1999-09-01 Issue:9 Volume:29 Page:434-437
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:Japanese Journal of Clinical Oncology

Author:

Adachi S.,Ogasawara T.,Yamasaki N.,Shibahara H.,Kanazawa R.,Tsuji Y.,Takemura T.,Koyama K.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/29/9/434/5102901/29-9-434.pdf

Reference18 articles.

1. Clinical studies of irinotecan alone and in combination with cisplatin

2. CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.

3. Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

4. Clear Cell Carcinoma of the Ovary: A Distinct Histologic Type with Poor Prognosis and Resistance to Platinum-Based Chemotherapy in Stage III Disease

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer;Journal of Ovarian Research;2024-02-12

2. Camptothecin Effectively Regulates Germline Differentiation through Bam–Cyclin A Axis in Drosophila melanogaster;International Journal of Molecular Sciences;2023-01-13

3. Clear cell carcinoma of the ovary: a clinical and molecular perspective;International Journal of Gynecologic Cancer;2020-09-18

4. Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer;Gynecologic Oncology;2017-02

5. Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial;Journal of Clinical Oncology;2016-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3